AzTrials
AzTrials

Knee OsteoarthritisROSA_RCTNCT05685693

ROSA Knee System vs Conventional Total Knee Arthroplasty

A study testing Robotic-assisted total knee arthroplasty (raTKA) and conventional total knee arthroplasty in people with Knee Osteoarthritis, run by Zuyderland Medisch Centrum at 1 site in Netherlands.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This is a randomized clinical study, in which 150 patients with end-stage osteoarthritis will be enrolled to ROSA®-assisted knee arthroplasty or conventional knee arthroplasty. Patients are recruited at Zuyderland Medical Center, enrolled pre-operatively and followed up for 12 months post-surgery. Read more about this study

Who is it for?
Ages 40 to 90 years
Conditions the study is for
Knee Osteoarthritis
What is being tested?
Robotic-assisted total knee arthroplasty (raTKA) and conventional total knee arthroplasty
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteNetherlands
Study dates
16 Dec 2022to Dec 2035
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Eligible for primary TKA
  • age 40-90 years
  • Body-Mass-Index 18.5-50.0 kg/m2
  • American Society of Anaesthesiologists Class I-III
  • Willingness and capability to understand and follow protocol

Who cannot join

  • Rheuma-/trauma-indicated knee arthroplasty

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Zuyderland Medical Center

    Sittard, Limburg, 6162 BG

Other trials in Netherlands

About this study

Official title: The Effect of ROSA®-Assisted Knee Arthroplasty on Clinical Outcomes

This is a randomized clinical study, in which 150 patients with end-stage osteoarthritis will be enrolled to ROSA®-assisted knee arthroplasty or conventional knee arthroplasty. Patients are recruited at Zuyderland Medical Center, enrolled pre-operatively and followed up for 12 months post-surgery. In- and exclusion criteria are stated below.

After recruitment, participants will be invited for a pre-operative visit. During this pre-operative visit Informed Consent is signed and completion of patient-reported outcome measures (PROMs) is checked. Additionally, measurements regarding body composition, strength and fitness and metabolic outcomes are performed. Participants will have a blood sample taken. Scans, adverse event and medication use will be confirmed. Participants will receive a ActiGraph for collecting data from physical activity. Of all patients, 72 will undergo additional measurements (gait, proprioception).

During surgery ROSA- and surgery-data will be collected. Post-operative participants will have a 6-weeks, 3-month and 12-month visit. During these visits pre-operative measurements are repeated.

Being tested
Robotic-assisted total knee arthroplasty (raTKA), conventional total knee arthroplasty
Keywords
Robotic-assisted arthroplasty, Knee arthroplasty, Gait, Metabolic Syndrome, ROSA Knee System, Physical Activity, Cost-effectiveness
Medical subject headings
Osteoarthritis, Knee, Metabolic Syndrome, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Robotic-assisted total knee arthroplasty (raTKA)Procedure or surgery

    Robotic-assisted total knee arthroplasty is an orthopaedic surgery that involves replacing the articular surfaces (femoral condyles and tibial plateau) of the knee joint with smooth metal and highly cross-linked polyethylene plastic. The robot (ROSA Knee System, Zimmer Biomet, US) assists in planning and placement of the implants and resection sites.

  • conventional total knee arthroplastyProcedure or surgery

    total knee arthroplasty is an orthopaedic surgery that involves replacing the articular surfaces (femoral condyles and tibial plateau) of the knee joint with smooth metal and highly cross-linked polyethylene plastic. In conventional TKAs, no patient-specific instrumentation or robotic assistance is provided.

Study groups in NCT05685693
Study groupRoleWhat they receive
Conventional TKAActive comparatorConventional TKA, with no patient-specific instrumentation or robotic assistance
Receives: Procedure: conventional total knee arthroplasty
Robotic-assisted TKAExperimentalROSA Knee System assisted TKA
Receives: Procedure: Robotic-assisted total knee arthroplasty (raTKA)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oxford Knee Score

    The Oxford Knee Score (OKS, best to worst 0-48) measures pain intensity and functional limitation of the knee during various activities. The questionnaire consists of 12 items. The maximum total score is 60 and corresponds with the highest pain intensity and functional limitation.

    Measured: 3-months post-operative

  2. Oxford Knee Score

    The Oxford Knee Score (OKS, best to worst 0-48) measures pain intensity and functional limitation of the knee during various activities. The questionnaire consists of 12 items. The maximum total score is 60 and corresponds with the highest pain intensity and functional limitation.

    Measured: 12-months post-operative

Secondary outcomes (29)
  1. Quality of Life-Index

    European Quality of Life-questionnaire-5-dimension-3-level (worst to best, -0.329 to 1.000)

    Measured: Pre-operative, 3-months and 12-months post-operative.

  2. Symptoms

    Western Ontario and McMaster Universities Osteoarthritis Index (worst to best 0-100)

    Measured: Pre-operative, 3-months and 12-months post-operative.

  3. Pain Catastrophizing

    Pain Catastrophizing Scale (best to worst, 0-52)

    Measured: Pre-operative, 3-months and 12-months post-operative.

  4. Pain Sensitivity

    Pain Sensitivity Questionnaire (best to worst, 0-140)

    Measured: Pre-operative, 3-months and 12-months post-operative.

  5. Mobility

    De Morten Mobility index (worst to best, 0-100)

    Measured: Pre-operative, 3-months and 12-months post-operative.

  6. Complications

    Registered complications during hospitalization

    Measured: During in-patient stay for indicated surgery (up to 5 days)

  7. Duration of surgery

    Registered duration of surgery

    Measured: During surgery

  8. Blood loss

    Registered blood loss during hospitalization

    Measured: During surgery

  9. Length of hospital stay

    Duration from patient intake until discharge

    Measured: During in-patient stay for indicated surgery (up to 5 days)

  10. Anesthesia

    Type of anesthesia used

    Measured: During surgery

  11. Stability of the knee

    Ligament tension, assessed by the ROSA Knee System

    Measured: Immediately after the surgery

  12. Knee implant position

    Resection, assessed by the ROSA Knee System

    Measured: Immediately after the surgery

  13. Mobility of the knee

    Flexion, Extension of knee, assessed by the ROSA Knee System

    Measured: During and immediately after the surgery

  14. Mechanical axis of the leg.

    Hip-Knee-Alignment, by CT

    Measured: 3-months post-surgery

  15. Implant Survival

    Duration until failure (required revision)

    Measured: 90-day and 1-year

  16. Patient Survival

    Duration until death

    Measured: 90-day and 1-year

  17. Physical Activity

    Steps per day, assessed for 7 continuous days using hip-worn accelerometer

    Measured: Pre-operative, 3-months and 12-months post-operative.

  18. Metabolic Syndrome

    Metabolic Syndrome Severity Scale (no predefined range, higher scores indicate worse outcome)

    Measured: Pre-operative, 3-months and 12-months post-operative.

  19. Body composition

    Fat mass, measured as % using bioimpedance analysis

    Measured: Pre-operative, 3-months and 12-months post-operative.

  20. Handgrip strength

    handgrip strength using hand-held dynamometer

    Measured: Pre-operative, 3-months and 12-months post-operative.

  21. Physical condition

    Completed distance in 2-minute walking

    Measured: Pre-operative, 3-months and 12-months post-operative.

  22. Physical strength

    Completed sit-to-stand-transfers within 30 seconds

    Measured: Pre-operative, 3-months and 12-months post-operative.

  23. Physical mobility

    Time to stand up, walk 3m back and forth and sit down again (timed-up-and-go test)

    Measured: Pre-operative, 3-months and 12-months post-operative.

  24. Cost of procedure, implants

    Number implant sizes readily available, and used

    Measured: During Surgery

  25. Cost of procedure, personnel

    Number of Personnel during surgery

    Measured: During Surgery

  26. Productivity

    Institute for Medical Technology Assessment Productivity Cost Questionnaire (worst to best, 0-100)

    Measured: Pre-operative, 3-months and 12-months post-operative.

  27. Medical consumption

    Institute for Medical Technology Assessment Medical Consumption Questionnaire (outcome in Euro)

    Measured: Pre-operative, 3-months and 12-months post-operative.

  28. Work Ability Index

    Work Ability Index Questionnaire (worst to best, 0-100)

    Measured: Pre-operative, 3-months and 12-months post-operative.

  29. Work Productivity and Activity Impairment

    Work Productivity and Activity Impairment-Questionnaire (worst to best, 0-100)

    Measured: Pre-operative, 3-months and 12-months post-operative.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jan 2023
  2. Study start16 Dec 2022
  3. Primary completionDec 2025 (estimated)
  4. Study completionDec 2035 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05685693
Sponsor's protocol ID
Z2021179
Acronym
ROSA_RCT
Status last verified
Jul 2024
First submitted
25 Nov 2022
Last updated
24 Jul 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Eijking HM, Dorling IM, van Haaren EH, Hendrickx R, Nijenhuis T, Schotanus MGM, Bouwman L, Most J, Boonen B. Image-based robotic (ROSA(R) knee system) total knee arthroplasty with inverse kinematic alignment compared to conventional total knee arthroplasty : Study protocol and the inverse kinematic alignment in 8-steps using the ROSA(R) Knee system for knee balancing technique explained. J Orthop Surg Res. 2025 Jan 15;20(1):47. doi: 10.1186/s13018-024-05427-y.

    PubMed 39815282

Questions about this trial

What is this clinical trial studying?

A study testing Robotic-assisted total knee arthroplasty (raTKA) and conventional total knee arthroplasty in people with Knee Osteoarthritis, run by Zuyderland Medisch Centrum at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 24 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oxford Knee Score (time frame: 3-months post-operative). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05685693, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
ROSA_RCT Clinical Trial NCT05685693 | AzTrials